Picture3.jpg
Israel-Based Clearmind Medicine Successfully Completes Production of CMND-100 Drug Candidate for Clinical Trial
January 10, 2023 08:30 ET | Clearmind Medicine Inc.
Tel Aviv, Israel / Vancouver, Canada, Jan. 10, 2023 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND) (CSE: CMND) (FSE: CWY) (“Clearmind” or the "company"), a biotech company focused on...
johnson fistel.jpg
BioLineRx Class Action Alert: Submit Your Losses to Johnson Fistel
January 05, 2023 13:40 ET | Johnson Fistel, LLP
SAN DIEGO, Jan. 05, 2023 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP announces that a class action lawsuit has commenced on behalf of investors of BioLineRx Ltd. (NASDAQ:...
BYND logo.jpg
CEO’s Letter to Shareholders
December 15, 2022 08:00 ET | BYND Cannasoft Enterprises, Inc.
ASHKELON, Israel and VANCOUVER, British Columbia, Dec. 15, 2022 (GLOBE NEWSWIRE) -- BYND Cannasoft Enterprises Inc. (Nasdaq: BCAN) (C.S.E.: BYND) ("BYND Cannasoft" or the "Company") today issued a...
Picture1.png
Maris-Tech Announces $3.4 Million of Order Backlog as of January 1, 2022
December 08, 2022 09:00 ET | Maris-Tech Ltd.
REHOVOT, Israel, Dec. 08, 2022 (GLOBE NEWSWIRE) -- Maris-Tech Ltd. (Nasdaq: MTEK) (“Maris-Tech” or the "Company"), a B2B provider of intelligent video transmission technology, today announced that...
logo.jpg
Medigus Announces Cash Capital Distribution of $1.6 Million
November 18, 2022 08:30 ET | Medigus Ltd
The Company will provide an update regarding the distribution date Tel Aviv, Israel, Nov. 18, 2022 (GLOBE NEWSWIRE) -- Medigus Ltd. (Nasdaq: MDGS), a technology company engaged in advanced medical...
BiondVax LOGO.png
BiondVax Announces Plan to Implement ADS Ratio Change
November 10, 2022 16:00 ET | BiondVax Pharmaceuticals Ltd.
JERUSALEM, Nov. 10, 2022 (GLOBE NEWSWIRE) -- via InvestorWire -- BiondVax Pharmaceuticals Ltd. (Nasdaq: BVXV) (“BiondVax”), a biotechnology company focused on developing, manufacturing, and...
BYND logo.jpg
Tel Aviv Listed Together Pharma’s Subsidiary Globus Pharma Ltd and BYND Cannasoft Enterprises’ Subsidiary Sign First Commercial Agreement for Medical Cannabis Products
October 27, 2022 09:00 ET | BYND Cannasoft Enterprises, Inc.
VANCOUVER, British Columbia and ASHKELON, Israel, Oct. 27, 2022 (GLOBE NEWSWIRE) -- BYND Cannasoft Enterprises Inc. (NASDAQ: BCAN) (CSE: BYND) ("BYND Cannasoft" or the "Company") announced today its...
BYND logo.jpg
Israeli Cannabis Technology Company BYND Cannasoft Enterprises Inc. and Matrix Medika to Explore Further (FDA) Development of the EZ-G Device
October 24, 2022 09:00 ET | BYND Cannasoft Enterprises, Inc.
VANCOUVER, British Columbia and ASHKELON, Israel, Oct. 24, 2022 (GLOBE NEWSWIRE) -- BYND Cannasoft Enterprises Inc. (NASDAQ: BCAN) (CSE: BYND) ("BYND Cannasoft" or the "Company") announced today...
Visit ArkOfIsrael.com
70th United States Secretary of State Mike Pompeo to Keynote Ark of Israel's Major Fundraising Event in Nashville in November
October 18, 2022 14:00 ET | Ark Of Israel
NASHVILLE, Tenn., Oct. 18, 2022 (GLOBE NEWSWIRE) -- Ark Of Israel is a nonprofit organization whose mission is to strengthen the unbreakable bond between the United States and Israel. The...
BioNTech CEO Ugur Sahin Visited Israel to Discuss Cooperation on Pandemic Preparedness and the Development of Innovative Medicines
September 07, 2022 02:00 ET | BioNTech SE
JERUSALEM, Israel, and MAINZ, Germany, September 7, 2022 —BioNTech SE (Nasdaq: BNTX) announced today that Prof. Ugur Sahin, CEO and Co-founder of BioNTech, visited Israel to meet with the Minister of...